Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatum

		Cancer Friends Network > Types of Cancer > Leukemia
Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatum

LinkBack

Thread Tools

Display Modes

#1 (permalink)

01-11-2012, 02:30 AM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,390

Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatum

Micromet announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute to expand development of the Company’s lead product candidate blinatumomab in patients with acute lymphoblastic leukemia and various sub-types of lymphoma.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 03:12 PM.

CancerFriends.net